Amarantus Bioscience Holdings Inc (AMBS)

$0.00 0.00 (N/A)
Market Cap 0.00
Revenue (ttm) 0.00
Net Income (ttm) -25.21M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,840,400
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 0.00
Stochastic %K N/A
Beta 1.41
Analysts Strong Buy
Price Target $0.65

Company Profile

Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company's diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer's disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic p...

Industry: Biotechnology
Sector: Healthcare
Phone: 650-862-5391
Address:
45 Wall Street, Suite 920, New York, United States
Skeetz99
Skeetz99 Dec. 22 at 1:11 PM
$AMBS What happened with this transaction? 2021-2022: Focused on MANF (Mesencephalic Astrocyte-Derived Neurotrophic Factor) platform for neurodegenerative/ophthalmic diseases, entering deals with Merck for chaperone activator discovery and licensing MANF assets.
0 · Reply
Bulldog_Retired
Bulldog_Retired Dec. 8 at 10:23 PM
$TOMDF $AMBS looks like many of the old Todos Med leaders formed TolloHealth in Tampa? Maybe just selling Dr Arad's products for her as a distributor? I'm pretty sure Dr Arad walked away with the IP for Tollovid when Todos folded https://tollohealth.com/about/
0 · Reply
Mandi63
Mandi63 May. 20 at 2:51 PM
$AEON $CDIO $SANA $AMBS $EOLS $AEON PUBLIC FLOAT 7.68 MILLION TWO CONFIRMED 5% SHAREHOLDERS NEW CEO BOUGHT 59,000 SHARES 25 YEARS EXPERIENCE 10 MILLION CASH upcoming conference MAY 19 th $1.00-5.00 PRICE TARGET $360.00
3 · Reply
Mandi63
Mandi63 May. 20 at 2:13 PM
$AEON $CDIO $SANA $AMBS LETS GO….$AEON MOVE IT $1.00 plus PARTNER $EOLS 10 MILLION CASH NEW CEO 25 YEARS EXPERIENCE FDA RESULTS AND MEETING ON ALREADY APPROVED MARKETED DRUG
0 · Reply
stockitch
stockitch Apr. 10 at 6:47 PM
$AMBS $IONQ $RGTI do bears speak English
1 · Reply
Ryanrable
Ryanrable Feb. 28 at 11:36 AM
$OSTX You’ve been warned… Gerald C is employed here… he crippled two other of his companies…. $AMBS $TOMDF
1 · Reply
Ryanrable
Ryanrable Feb. 3 at 11:33 AM
$OSTX Gerald C taking your money, told ya… Dilution is his game…. You’ve been warned …. Two companies he did this to…. $TOMDF $AMBS
1 · Reply
Ryanrable
Ryanrable Jan. 6 at 6:21 PM
$OSTX Gerald C gonna suck this stock dry… Warning will warning…. $AMBS $TOMDF both of his fails
2 · Reply
Ryanrable
Ryanrable Jan. 2 at 1:28 AM
$OSTX Beware Gerald C is employees here… $AMBS $TOMDF
1 · Reply
Ryanrable
Ryanrable Dec. 27 at 11:31 PM
$OSTX Gerald C is employeed here This will surely fail…. He ran two other companies to the ground…. $TOMDF $AMBS
2 · Reply
Latest News on AMBS
No data available.
Skeetz99
Skeetz99 Dec. 22 at 1:11 PM
$AMBS What happened with this transaction? 2021-2022: Focused on MANF (Mesencephalic Astrocyte-Derived Neurotrophic Factor) platform for neurodegenerative/ophthalmic diseases, entering deals with Merck for chaperone activator discovery and licensing MANF assets.
0 · Reply
Bulldog_Retired
Bulldog_Retired Dec. 8 at 10:23 PM
$TOMDF $AMBS looks like many of the old Todos Med leaders formed TolloHealth in Tampa? Maybe just selling Dr Arad's products for her as a distributor? I'm pretty sure Dr Arad walked away with the IP for Tollovid when Todos folded https://tollohealth.com/about/
0 · Reply
Mandi63
Mandi63 May. 20 at 2:51 PM
$AEON $CDIO $SANA $AMBS $EOLS $AEON PUBLIC FLOAT 7.68 MILLION TWO CONFIRMED 5% SHAREHOLDERS NEW CEO BOUGHT 59,000 SHARES 25 YEARS EXPERIENCE 10 MILLION CASH upcoming conference MAY 19 th $1.00-5.00 PRICE TARGET $360.00
3 · Reply
Mandi63
Mandi63 May. 20 at 2:13 PM
$AEON $CDIO $SANA $AMBS LETS GO….$AEON MOVE IT $1.00 plus PARTNER $EOLS 10 MILLION CASH NEW CEO 25 YEARS EXPERIENCE FDA RESULTS AND MEETING ON ALREADY APPROVED MARKETED DRUG
0 · Reply
stockitch
stockitch Apr. 10 at 6:47 PM
$AMBS $IONQ $RGTI do bears speak English
1 · Reply
Ryanrable
Ryanrable Feb. 28 at 11:36 AM
$OSTX You’ve been warned… Gerald C is employed here… he crippled two other of his companies…. $AMBS $TOMDF
1 · Reply
Ryanrable
Ryanrable Feb. 3 at 11:33 AM
$OSTX Gerald C taking your money, told ya… Dilution is his game…. You’ve been warned …. Two companies he did this to…. $TOMDF $AMBS
1 · Reply
Ryanrable
Ryanrable Jan. 6 at 6:21 PM
$OSTX Gerald C gonna suck this stock dry… Warning will warning…. $AMBS $TOMDF both of his fails
2 · Reply
Ryanrable
Ryanrable Jan. 2 at 1:28 AM
$OSTX Beware Gerald C is employees here… $AMBS $TOMDF
1 · Reply
Ryanrable
Ryanrable Dec. 27 at 11:31 PM
$OSTX Gerald C is employeed here This will surely fail…. He ran two other companies to the ground…. $TOMDF $AMBS
2 · Reply
Ryanrable
Ryanrable Dec. 19 at 6:54 AM
$OSTX Be warned $AMBS $TOMDF Two of Gerald’s fails
2 · Reply
HyperionOptics
HyperionOptics Oct. 8 at 1:51 PM
$AMBS what's going on here? Hyperion loves waking up to a 4,000,000% gain!! Coming back to life???
7 · Reply
KSIrockedPaul
KSIrockedPaul May. 25 at 11:23 AM
$AMBS $RGBP $TOMDF $USEI, I wonder how many have been delisted since?
0 · Reply
Vizzini
Vizzini May. 2 at 5:01 PM
$AMBS is burdened with a substantial debt and is currently in a state of financial standstill, with no income. This is a grave situation, and legal action from creditors could be just around the corner. The potential consequences for MANF and other IPs are dire, as they may face a fate similar to TODOS. This is a company run by a CEO with no credibility. GC, this is a critical moment for your legacy as a two-time loser.
0 · Reply
MooseChuck
MooseChuck May. 2 at 2:48 PM
$AMBS Wasn't there supposed to be an update on April 30th?
1 · Reply
Mandi63
Mandi63 Apr. 29 at 11:38 AM
$AMBS just seems to be a cover title for Gerald.. CEO of Amarantus Bioscience
0 · Reply
Beefcake35
Beefcake35 Apr. 25 at 5:06 PM
$AMBS this one done?
1 · Reply
freegriff
freegriff Mar. 30 at 5:02 AM
$AMBS Magna dependents have agreed to SEC settlement language and the settlement is under final review by SEC for approval and Judges signature. Next update April 30. Hope to see some text soon and find out to what extent this judgement will benefit Amarantus.
5 · Reply